A House Energy and Commerce Health Subcommittee hearing on June 11, 2009 will focus on a new Federal Trade Commission (FTC) report titled "Emerging Health Care Issues: Follow-on Biologic Drug Competition." The report will describe findings from an FTC nvestigation into the effects of a follow-on biologics pathway on competition and innovation. In particular, the report will address whether additional incentives, beyond those provided by patents and pricing, are needed to ensure continued innovation in the biologics market.
- How-to guide How-to guide: How to prepare for and respond to a governmental investigation or enforcement action for violation of US privacy laws (USA)
- How-to guide How-to guide: How to develop a vulnerability disclosure program (VDP) for your organization to ensure cybersecurity (USA)
- How-to guide How-to guide: How to draft and negotiate limitation of liability clauses (USA)